Folic acid functionalized gelatin-coated mesoporous hollow carbon nanospheres (FGMCN) were synthesized and applied to enhance the antitumor curative effect of paclitaxel (PTX) for human liver cancer cell lines (SMMC-7721). PTX was loaded in FGMCN by the adsorption method and the PTX-loaded samples (PTX-FGMCN) had a drug content of 29.8 ± 1.06%. The PTX-FGMCN with a sustained release effect was characterized by X-ray diffraction and differential scanning calorimeter in order to analyze the PTX state in FGMCN. In vitro cell experiments showed that FMHSN improves the uptake of PTX and promotes apoptosis due to the nano-targeting effect of FMHSN. An in vivo tumor bearing experiment in mice indicated that the PTX-FGMCN significantly inhibited the growth of tumors. All of these results suggested that the PTX-FGMCN may be an effective anti-hepatoma drug in the future.
QinPHanTYuACH, et al.
Mechanistic understanding the bioeffects of ultrasound-driven microbubbles to enhance macromolecule delivery. J Control Release2018;
272: 169–181.
2.
AldemarGGClaudiaE.Solid lipid nanoparticles and nanostructured lipid carriers: a review emphasizing on particle structure and drug release. Eur J Pharm Biopharm2018;
133: 285–308.
3.
NilimaTPParvaJJigarV, et al.
Solid lipid nanoparticles as an efficient drug delivery system of olmesartan medoxomil for the treatment of hypertension. Collid Surface B2018;
165: 37–44.
4.
LiYLuALLongMM, et al.
Nitroimidazole derivative incorporated liposomes for hypoxia-triggered drug delivery and enhanced therapeutic efficacy in patient-derived tumor xenografts. Acta Biomater2019;
83: 334–348.
5.
ZhangPCHuLJYinQ, et al.
Transferrin-conjugated polyphosphoester hybrid micelle loading paclitaxel for brain-targeting delivery: synthesis, preparation and in vivo evaluation. J Control Release2012;
159: 429–434.
6.
AghajanzadehMZamaniMRashidzadehH, et al.
Amphiphilic Y shaped miktoarm star copolymer for anticancer hydrophobic and hydrophilic drugs codelivery: synthesis, characterization, in vitro, and in vivo biocompatibility study. J Biomed Mater Res A2018;
106: 2817–2826.
7.
MozhganAFarhangGMostafaZ, et al.
Anti-inflammatory effect of rosuvastatin using diblock amphiphilic copolymer: synthesis, characterization, in vitro and in vivo study. J Biomater Appl2019;
34: 229–238.
8.
LiHRWuXQYangBX, et al.
Evaluation of biomimetically synthesized mesoporous silica nanoparticles as drug carriers: structure, wettability, degradation, biocompatibility and brain distribution. Mat Sci Eng C Mater2019;
94: 453–464.
9.
XueXBLuSYWuC, et al.
Curcumin polymer coated, self-fluorescent and stimuli-responsive multifunctional mesoporous silica nanoparticles for drug delivery. Micropor Mesopor Mat2018;
271: 234–242.
10.
KaramanDṢPatrignaniGRosqvistE, et al.
Mesoporous silica nanoparticles facilitating the dissolution of poorly soluble drugs in orodispersible films. Eur J Pharm Sci. 2018;
122: 152–159.
11.
RanFLeiWCuiY, et al.
Size effect on oral absorption in polymer-functionalized mesoporous carbon nanoparticles. J Colloid Interface Sci. 2018;
511: 57–66.
12.
WanLWangXFZhuWQ, et al.
Folate-polyethyleneimine functionalized mesoporous carbon nanoparticles for enhancing oral bioavailability of paclitaxel. Int J Pharmaceut2015;
484: 207–217.
13.
AhirMBhattacharyaSKarmakarS, et al.
Tailored-CuO-nanowire decorated with folic acid mediated coupling of the mitochondrial-ROS generation and miR425-PTEN axis in furnishing potent anti-cancer activity in human triple negative breast carcinoma cells. Biomaterials2016;
76: 115–132.
14.
LiHLiYJiaoJ, et al.
Alpha-alumina nanoparticles induce efficient autophagy-dependent cross-presentation and potent antitumour response. Nat Nanotechnol2011;
6: 645–650.
15.
RosenJEChanLShiehDB, et al.
Iron oxide nanoparticles for targeted cancer imaging and diagnostics. Nanomedicine2012;
3: 275–290.
16.
MortezaAMohammadKShahinA, et al.
Magnetic nanoparticles decorated with PEGylated curcumin as dual targeted drug delivery: synthesis, toxicity and biocompatibility study. Mat Sci Eng C Mater2019;
104: 109810.
17.
LiWGuoZZhengK, et al.
Dual targeting mesoporous silica nanoparticles for inhibiting tumour cell invasion and metastasis. Int J Pharm2017;
534: 71–80.
18.
KimKSHurWParkSJ, et al.
Bioimaging for targeted delivery of hyaluronic acid derivatives to the livers in cirrhotic mice using quantum dots. ACS Nano2010;
4: 3005–3014.
19.
DramouPFizirMTalebA, et al.
Folic acid-conjugated chitosan oligosaccharide-magnetic halloysite nanotubes as a delivery system for camptothecin. Carbohydr Polym2018;
197: 117–127.
20.
FengSNZhangHJXuS, et al.
Folate-conjugated, mesoporous silica functionalized boron nitride nanospheres for targeted delivery of doxorubicin. Mat Sci Eng C Mater2019;
96: 552–560.
21.
LiuLZongZMLiuQ, et al.
A novel galactose-PEG-conjugated biodegradable copolymer is an efficient gene delivery vector for immunotherapy of hepatocellular carcinoma. Biomaterials2018;
184: 20–30.
22.
SunYDaiCYinM, et al.
Hepatocellular carcinoma-targeted effect of configurations and groups of glycyrrhetinic acid by evaluation of its derivative-modified liposomes. IJN2018;
13: 1621–1632.
23.
FuQHargroveDLuXL.Improving paclitaxel pharmacokinetics by using tumor-specific mesoporous silica nanoparticles with intraperitoneal delivery. Nanomed Nanotechnol2016;
12: 1951–1959.
24.
HeYJLiangSQLongMQ, et al.
Mesoporous silica nanoparticles as potential carriers for enhanced drug solubility of paclitaxel. Mat Sci Eng C Mater2017;
78: 12–17.
25.
JiZFLinGFLuQH, et al.
Targeted therapy of SMMC-7721 liver cancer in vitro and in vivo with carbon nanotubes based drug delivery system. J Colloid Interface Sci2012;
365: 143–149.
26.
ZhangHNoonanOHuangX, et al.
Surfactant-free assembly of mesoporous carbon hollow spheres with large tunable pore sizes. ACS Nano2016;
10: 4579–4586.
27.
XuXYWuCBaiAD, et al.
Folate-functionalized mesoporous silica nanoparticles as a liver tumor-targeted drug delivery system to improve the antitumor effect of paclitaxel. J Nanomater2017;
2017: 1–13.
28.
ZhangLKHouSXZhangJQ, et al.
Preparation, characterization, and in vivo evaluation of mitoxantrone-loaded, folate-conjugated albumin nanoparticles. Arch Pharm Res2010;
33: 1193–1198.
29.
QiuYWuCJiangJ, et al.
Lipid-coated hollow mesoporous silica nanospheres for co-delivery of doxorubicin and paclitaxel: preparation, sustained release, cellular uptake and pharmacokinetics. Mater Sci Eng C Mater Biol Appl2017;
71: 835–843.
30.
SuCLiHShiY, et al.
Carboxymethyl- -cyclodextrin conjugated nanoparticles facilitate therapy for folate receptor-positive tumor with the mediation of folic acid. Int J Pharm. 2014;
474: 202–211.
31.
WuCGaoYLiuY, et al.
Pure paclitaxel nanoparticles: preparation, characterization, and antitumor effect for human liver cancer sMMc-7721 cells. IJN. 2018;
13: 6189–6198.
32.
SunYHuiQRChenR, et al.
Apoptosis in human hepatoma HepG2 cells induced by the phenolics of Tetrastigma hemsleyanum leaves and their antitumor effects in H22 tumor-bearing mice. J Funct Foods2018;
40: 349–364.
33.
ZhangYZhiZJiangT, et al.
Spherical mesoporous silica nanoparticles for loading and release of the poorly water-soluble drug telmisartan. J Control Release2010;
145: 257–263.
34.
ChenCSunWWangXL, et al.
pH-responsive nanoreservoirs based on hyaluronic acid end-capped mesoporous silica nanoparticles for targeted drug delivery. Int J Biol Macromol2018;
111: 1106–1115.
